A
$ Value
$0
Shares
40,006
Price
$0
Filed
Jun 16
Insider
Name
Castelein Caley
Title
—
CIK
0001355758
Roles
Director
Transaction Details
Transaction Date
2025-06-12
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
40,006
Footnotes
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2025.
Filing Info
Castelein Caley's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-28 | TRML | U | — |
| 2025-10-28 | TRML | U | — |
| 2025-10-28 | TRML | D | — |
| 2025-10-28 | TRML | D | — |
| 2025-10-28 | TRML | D | — |
| 2025-10-15 | TRML | G | $0 |
| 2025-06-12 | WHWK | A | $0 |
| 2025-06-04 | TRML | A | $0 |
Other Insiders at WHWK (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
|
— | $891K | 2026-04-16 |
|
BALL BRYAN
See remarks
|
— | $635K | 2026-04-14 |
|
Dornan David
Chief Scientific Officer
|
— | — | 2026-04-01 |
|
Dugan Margaret
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Lennon David James
CHIEF EXECUTIVE OFFICER
|
— | $1.1M | 2026-04-09 |